The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohort

[1]  Christopher Jones,et al.  Reliability of the Calgary depression scale for schizophrenia: A meta-analysis , 2021, Schizophrenia Research.

[2]  L. Gregg,et al.  Expressed Emotion and Attributions in Parents With Schizophrenia , 2021, Frontiers in Psychiatry.

[3]  Zhening Liu,et al.  Evaluation on Long-Term Test–Retest Reliability of the Short-Form Childhood Trauma Questionnaire in Patients with Schizophrenia , 2021, Psychology research and behavior management.

[4]  C. Nievergelt,et al.  Gene–environment correlations and causal effects of childhood maltreatment on physical and mental health: a genetically informed approach , 2021, The lancet. Psychiatry.

[5]  M. Leboyer,et al.  Understanding the genetic contribution of the human leukocyte antigen system to common major psychiatric disorders in a world pandemic context , 2020, Brain, Behavior, and Immunity.

[6]  A. Loundou,et al.  Comorbid Major Depressive Disorder in Schizophrenia: A Systematic Review and Meta-Analysis. , 2020, Schizophrenia bulletin.

[7]  K. Abel,et al.  Prevalence of parental mental illness and association with socioeconomic adversity among children in Sweden between 2006 and 2016: a population-based cohort study. , 2020, The Lancet. Public health.

[8]  B. Aouizerate,et al.  The puzzle of quality of life in schizophrenia: putting the pieces together with the FACE-SZ cohort , 2020, Psychological Medicine.

[9]  M. Hasselberg,et al.  Association between maternal and paternal mental illness and risk of injuries in children and adolescents: nationwide register based cohort study in Sweden , 2020, BMJ.

[10]  R. Murray,et al.  Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis. , 2020, The lancet. Psychiatry.

[11]  G. Fond,et al.  Chronic peripheral inflammation is associated with impaired functional remission independently of symptomatic remission and depression in schizophrenia. , 2020, Progress in neuro-psychopharmacology & biological psychiatry.

[12]  M. Leboyer,et al.  Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort , 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[13]  A. Lundervold,et al.  Test–Retest Reliability of the 25-item version of Wender Utah Rating Scale. Impact of Current ADHD Severity on Retrospectively Assessed Childhood Symptoms , 2019, Journal of attention disorders.

[14]  Dongjian Zhu,et al.  CACNA1C (rs1006737) may be a susceptibility gene for schizophrenia: An updated meta‐analysis , 2019, Brain and behavior.

[15]  Mirko Manchia,et al.  Peripheral Biomarkers in Schizophrenia: A Meta-Analysis of Microarray Gene Expression Datasets , 2018, The international journal of neuropsychopharmacology.

[16]  J. Leonardi-Bee,et al.  The effects of tobacco smoking, and prenatal tobacco smoke exposure, on risk of schizophrenia: a systematic review and meta-analysis. , 2018, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[17]  M. Leboyer,et al.  Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort. , 2018, The British journal of psychiatry : the journal of mental science.

[18]  L. Campbell,et al.  Severity of illness and adaptive functioning predict quality of care of children among parents with psychosis: A confirmatory factor analysis , 2018, The Australian and New Zealand journal of psychiatry.

[19]  G. Fond,et al.  Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset , 2017, Schizophrenia Research.

[20]  T. Kwapil,et al.  Relatives' expressed emotion, distress and attributions in clinical high-risk and recent onset of psychosis , 2017, Psychiatry Research.

[21]  M. Leboyer,et al.  Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort , 2017, Schizophrenia Research.

[22]  G. Fond,et al.  Determination of Adherence Profiles in Schizophrenia Using Self-Reported Adherence: Results From the FACE-SZ Dataset. , 2016, The Journal of clinical psychiatry.

[23]  G. Fond,et al.  Validation of the Medication Adherence Rating Scale in homeless patients with schizophrenia: Results from the French Housing First experience , 2016, Scientific Reports.

[24]  Melissa J. Green,et al.  Effects of maltreatment and parental schizophrenia spectrum disorders on early childhood social-emotional functioning: a population record linkage study , 2016, Epidemiology and Psychiatric Sciences.

[25]  S. Priebe,et al.  How to support patients with severe mental illness in their parenting role with children aged over 1 year? A systematic review of interventions , 2015, Social Psychiatry and Psychiatric Epidemiology.

[26]  S. Woods,et al.  Dose equivalents for second-generation antipsychotics: the minimum effective dose method. , 2014, Schizophrenia bulletin.

[27]  Rudolf Uher,et al.  Gene–Environment Interactions in Severe Mental Illness , 2014, Front. Psychiatry.

[28]  M. Alda,et al.  Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: a meta-analysis of family high-risk studies. , 2013, Schizophrenia bulletin.

[29]  K. Berry,et al.  The role of expressed emotion in relationships between psychiatric staff and people with a diagnosis of psychosis: a review of the literature. , 2011, Schizophrenia bulletin.

[30]  A. Bertelsen,et al.  Severe mental disorders in offspring with 2 psychiatrically ill parents. , 2010, Archives of general psychiatry.

[31]  E. Steyerberg.  Clinical Prediction Models , 2008, Statistics for Biology and Health.

[32]  N. Haslam,et al.  Expressed emotion, attributions, utility beliefs, and distress in parents of young people with first episode psychosis , 2007, Psychiatry Research.

[33]  J. Read,et al.  Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications , 2005, Acta psychiatrica Scandinavica.

[34]  A. R.,et al.  Review of literature , 1960, American Potato Journal.

[35]  S. Lange,et al.  Adjusting for multiple testing--when and how? , 2001, Journal of clinical epidemiology.

[36]  M. Stein,et al.  Factorial validity of the Childhood Trauma Questionnaire in men and women , 2001, Depression and anxiety.

[37]  C. Lançon,et al.  Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS) , 2000, Schizophrenia Research.

[38]  C. Lançon,et al.  Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS). , 2000, Journal of affective disorders.

[39]  M. Slade,et al.  A self‐report Insight Scale for psychosis: reliability, validity and sensitivity to change , 1994, Acta psychiatrica Scandinavica.

[40]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.